ANDA 40029, held by Ani Pharms. Sodium Polystyrene Sulfonate.
As of Nov 16, 2026, ANDA 40029 (Kionex), held by Ani Pharms, was first approved by FDA on Feb 6, 1998, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 1998 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Kionex454GM/BOT · powder;oral, rectal | Sodium Polystyrene Sulfonate | Rx |
| Mar 16, 2020 | Supplement 17Labeling · Standard review | Approved | None posted |
| Sep 26, 2012 | Supplement 16Labeling | Approved | None posted |
| Dec 8, 2011 | Supplement 15Labeling | Approved | None posted |
| Feb 6, 1998 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters